based on data from the eusilc survey unmet need for medical care due to cost distance and other reasons in denmark is relatively low with only of the population reporting such unmet needs compared to the eu average of figure coverage decisions for new pharmaceuticals are relatively quick taking between one and two months in denmark residents have the right to seek treatment anywhere in the country if their home region does not provide a service delivered elsewhere in these cases the home region needs to cover the expenses of treatment this includes a project to collect and store genetic information from people and a funding pool to enable precision medicine research patients with high annual outpatient medicine expenses over dkk s or eur and those with low personal assets below dkk s or eur receive reimbursement for all drugs commonwealth fund